Skip to main content
# Title Department Research Member Research Year
291 Assessment of Humoral Immune Recovery in Children with Hematological malignancies after Completion of Chemotherapy Department of Pediatric Oncology Rania Taha Mohammed Ahmed 2021
292 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
Department of Biostatistics and Cancer Epidemiology Basma Rezk Farouk Saleh 2021
293 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Ayat allah Ali yousseif 2021
294 Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR over expression and overall survival Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
295 Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Asmaa Mohamed Zahran Omar 2021
296 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Mohamed Ismail Omar Ali 2021
297 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
298 First Relapse of Acute Lymphoblastic Leukemia in Children in Upper Egypt: Survival Outcome and Prognostic Factors Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2021
299 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021
300 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2021